Regenerative biosignals, formulated for topical application.
BioSignal's platform harnesses Stem Cell Conditioned Media (SCCM) — a complex biological secretome of growth factors, exosomes, cytokines, and signaling molecules — delivered through characterized topical formulations across three therapeutic verticals.
What SCCM is — and why the source matters.
Stem Cell Conditioned Media is the biologically active fluid produced by mesenchymal stem cells under defined culture conditions. It contains thousands of bioactive molecules including growth factors, exosomes, and cytokines. Selecting the right stem cell niche and qualified donor source is critical to both therapeutic activity and long-term safety.
Signaling proteins that participate in tissue-response, inflammation modulation, and cellular recruitment.
Nanoscale extracellular vesicles carrying intercellular signaling cargo across membranes.
Immunomodulatory messengers governing local inflammation and repair dynamics.
The full collective of proteins, lipids, and nucleic acids secreted under defined conditions.
Where the portfolio is focused.
Each vertical addresses a high-demand therapeutic or aesthetic market with clinically observed, cell-free biologics formulated for targeted topical application.
Anti-aging, active acne reduction, scar remodeling, and stretch marks — targeting fine lines, hyperpigmentation, and dermal renewal across skin types.
Therapeutic creams and serums for vascular wounds, bed sores, venous ulcers, diabetic neuropathy, and foot conditioning — conditions with limited effective options today.
SCCM serums designed to support follicular regeneration and manage hair growth cycles — a science-backed alternative to conventional restoration.
Six SCCM formulations in active use.
Formulations with documented protocols and clinical case series. See the Case Studies page for observed outcomes and referenced peer-reviewed publications.
Daily topical SCCM serum for fine lines, tone, texture, and elasticity — used alone or paired with microneedling protocols.
Anti-inflammatory SCCM formulation targeting active acne lesions and post-acne / hypertrophic scar remodeling.
SCCM topical applied to the feet for symptomatic relief of diabetic peripheral neuropathy — pilot published in Am J Biomed Sci & Res.
Weekly-application SCCM serum designed to support closure of chronic diabetic wounds and vascular ulcers.
SCCM formulation aimed at supporting dermal remodeling in striae distensae.
SCCM topical for photo-damaged skin — burn-response support and post-exposure recovery.
Six additional SCCM formulations in development.
Formulations progressing through characterization and process development. Timing subject to regulatory pathway and manufacturing validation.
SCCM spray + collagen co-treatment for pressure ulcers.
SCCM formulation targeting sub-dermal connective tissue appearance.
SCCM formulation for atopic and inflammatory skin conditions.
Follicular-support SCCM serum used with 0.25–1.0 mm microneedling / dermal stamp protocols.
Maintenance SCCM cream for at-risk diabetic feet — companion to neuropathy and ulcer lines.
SCCM formulation for weak, brittle, or damaged nails.
- Skin Care
- 5
- Diabetic Care
- 4
- Hair / Nail
- 2
- Dermatology
- 1